Laverock Therapeutics awarded in excess of £2.2M in grants for gene-control platform

Laverock Therapeutics announced it has been awarded two new grants totalling in excess of £2.2M to support the next generation of its gene-control platform development, and expansion into additional non-oncology therapeutics areas. The new grants provide further validation for Laverock’s differentia...